Novo Nordisk Price to Sales Ratio 2006-2019 | NVO

Historical PS ratio values for Novo Nordisk (NVO) over the last 10 years. The current P/S ratio for Novo Nordisk as of October 15, 2019 is .
Novo Nordisk P/S Ratio Historical Data
Date Stock Price TTM Sales per Share Price to Sales Ratio
2019-10-15 52.47 7.32
2019-06-30 51.04 $7.17 7.12
2019-03-31 52.31 $7.08 7.39
2018-12-31 46.07 $7.04 6.55
2018-09-30 47.14 $7.21 6.54
2018-06-30 45.68 $7.12 6.41
2018-03-31 48.77 $7.02 6.95
2017-12-31 52.28 $6.83 7.65
2017-09-30 46.91 $6.73 6.97
2017-06-30 41.35 $6.66 6.21
2017-03-31 33.05 $6.60 5.01
2016-12-31 33.89 $6.54 5.18
2016-09-30 39.30 $6.49 6.05
2016-06-30 50.33 $6.42 7.84
2016-03-31 50.71 $6.33 8.02
2015-12-31 53.42 $6.21 8.60
2015-09-30 49.88 $6.15 8.11
2015-06-30 50.36 $6.11 8.24
2015-03-31 49.10 $6.07 8.09
2014-12-31 38.34 $6.01 6.38
2014-09-30 43.14 $5.90 7.32
2014-06-30 41.85 $5.74 7.29
2014-03-31 41.36 $5.62 7.36
2013-12-31 32.86 $5.51 5.96
2013-09-30 30.09 $5.37 5.61
2013-06-30 27.56 $5.23 5.27
2013-03-31 28.72 $5.06 5.68
2012-12-31 28.46 $4.88 5.84
2012-09-30 27.52 $4.70 5.86
2012-06-30 25.35 $4.57 5.55
2012-03-31 24.19 $4.42 5.47
2011-12-31 19.75 $4.31 4.59
2011-09-30 17.05 $4.19 4.07
2011-06-30 21.47 $4.10 5.23
2011-03-31 21.46 $3.95 5.43
2010-12-31 19.01 $3.78 5.03
2010-09-30 16.62 $3.62 4.60
2010-06-30 13.68 $3.45 3.97
2010-03-31 13.02 $3.31 3.93
2009-12-31 10.59 $3.21 3.30
2009-09-30 10.44 $3.07 3.41
2009-06-30 9.03 $2.97 3.04
2009-03-31 7.96 $2.66 2.99
2008-12-31 8.34 $2.62 3.18
2008-09-30 8.31 $2.57 3.24
2008-06-30 10.71 $2.44 4.38
2008-03-31 11.23 $1.97 5.71
2007-12-31 10.39 $1.83 5.69
2007-09-30 9.70 $1.78 5.45
2007-06-30 8.70 $1.66 5.24
2007-03-31 7.25 $2.01 3.62
2006-12-31 6.60 $1.91 3.46
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $123.207B $17.724B
Novo Nordisk is a world leader in insulin and diabetes care and also manufactures and markets a variety of other pharmaceutical products. Furthermore the company is the world's largest producer of industrial enzyme products. The company believes that everyone must care for the environment and our natural resources.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $344.992B 15.02
Roche Holding AG (RHHBY) Switzerland $246.683B 0.00
Merck (MRK) United States $216.838B 17.83
Pfizer (PFE) United States $200.777B 11.82
Novartis AG (NVS) Switzerland $196.934B 16.95
AstraZeneca (AZN) United Kingdom $115.026B 22.25
Sanofi (SNY) France $112.411B 13.81
AbbVie (ABBV) United States $109.053B 8.74
GlaxoSmithKline (GSK) United Kingdom $105.181B 13.22
Eli Lilly (LLY) United States $104.170B 19.44
Bristol-Myers Squibb (BMY) United States $84.340B 11.96
Bayer (BAYRY) Germany $67.293B 9.80
H Lundbeck (HLUYY) Denmark $6.598B 9.52